European Journal of Surgical Oncology
Volume 36, Issue 3 , Pages 251-256, March 2010

Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum – Toxicity and complications of the treatment

  • R. Soumarova

      Affiliations

    • Department of Radiotherapy and Oncology, J. G. Mendel Cancer Center Novy Jicin, Purkynova 2138/16, Novy Jicin, 741 01, Czech Republic
    • Corresponding Author InformationCorresponding author. Tel.: +420 556 794 180.
  • ,
  • M. Skrovina

      Affiliations

    • Department of Surgery, J. G. Mendel Cancer Center Novy Jicin, Czech Republic
  • ,
  • J. Bartos

      Affiliations

    • Department of Surgery, J. G. Mendel Cancer Center Novy Jicin, Czech Republic
  • ,
  • J. Gruna

      Affiliations

    • Department of Radiotherapy and Oncology, J. G. Mendel Cancer Center Novy Jicin, Purkynova 2138/16, Novy Jicin, 741 01, Czech Republic
  • ,
  • A. Wendrinski

      Affiliations

    • Department of Radiotherapy and Oncology, J. G. Mendel Cancer Center Novy Jicin, Purkynova 2138/16, Novy Jicin, 741 01, Czech Republic
  • ,
  • S. Czudek

      Affiliations

    • Department of Surgery, J. G. Mendel Cancer Center Novy Jicin, Czech Republic
  • ,
  • R. Kycina

      Affiliations

    • Department of Surgery, J. G. Mendel Cancer Center Novy Jicin, Czech Republic
    • Surgical Clinic of Martin Faculty Hospital, Jessenius Medical Faculty of Commenius University, Martin, Slovakia
  • ,
  • J. Parvez

      Affiliations

    • Department of Surgery, J. G. Mendel Cancer Center Novy Jicin, Czech Republic

Accepted 1 October 2009.

Abstract 

Aims

The aim of this prospective study is to elucidate feasibility of protocol of neoadjuvant concomitant radiochemotherapy with capecitabine and long course radiotherapy with subsequent laparoscopic rectal resection. We assessed treatment toxicity, downstaging rate, pathological response to the neoadjuvant treatment, surgery complications, rate of conversions and sphincter-preserving surgical procedures, and intraoperative and early postoperative complications too.

Methods

We acquired data of 78 patients from 1 January 2005 to 31 December 2007 with a locally advanced rectal cancer in our study. All patients were indicated for the neoadjuvant concomitant chemoradiotherapy due to locally advanced tumor (T3 or T4) or lymph nodes involvement suspicion (N+). Both radiotherapy (to pelvic region) and chemotherapy (capecitabine) were administered. Rectal tumors were localized within 12cm from the anocutaneous verge. The average follow-up time was 23.9 months.

Results

All patients completed their treatment according to the planned regimen and dose. The surgery was performed laparoscopicaly within 4–8 weeks following the concomitant chemoradiotherapy – in 17% cases was converted into conventional surgery. Downstaging was achieved in 69% of patients, pathological complete response in 10%, histologically negative lymph nodes were documented in 58% of patients. Grade 3 toxicity of the concomitant chemoradiotherapy was present in 3%; grade 2 in 29% of patients, particularly skin and gastrointestinal form. Intraoperative and early postoperative complications of the surgery were 18%. Re-operation was needed in 5% cases.

Conclusions

We demonstrated safety and low toxicity of the concomitant chemoradiotherapy with capecitabine.

Keywords: Rectal cancer, Laparoscopy, Neoadjuvant concomitant chemoradiotherapy, Capecitabine, Treatment toxicity

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0748-7983(09)00471-5

doi:10.1016/j.ejso.2009.10.002

European Journal of Surgical Oncology
Volume 36, Issue 3 , Pages 251-256, March 2010